Does Ozempic really destroy muscle, and can pilates fix it?
Quick answer
After two years on tirzepatide (Mounjaro) with minimal resistance training, this creator presents a clinically common post-GLP-1 phenotype: significant weight loss accompanied by lean body mass reduction and residual loose skin, particularly in the arms, inner thighs, and abdomen. She is now initiating reformer pilates as a muscle-rebuilding intervention, which is consistent with evidence-based recommendations for resistance training post-GLP-1 therapy, though pilates alone may be insufficient stimulus for full lean mass restoration without concurrent progressive overload and adequate protein intake. Loose skin in the areas she describes is unlikely to resolve with exercise alone and may require dermatological or surgical evaluation depending on severity.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @chanelica.r actually say?
After two years on GLP-1 medications, primarily Mounjaro (tirzepatide), @chanelica.r returned to exercise for the first time and shared something a lot of people on these drugs don't want to admit: the weight came off, but so did muscle. She describes having loose skin on her arms, inner thighs, and midsection, and she's framing pilates as the fix, saying "this is gonna be perfect" for rebuilding what she lost. She also candidly notes she did very little structured exercise during her two years on the medication, mostly walking, then less of that over time.
That honesty is actually rare in GLP-1 content, and it matters. The claim she's building toward is that resistance-based movement like pilates can reverse muscle loss and tighten loose skin. Let's take those apart separately, because they are not the same thing scientifically.
Does the science back this up?
The muscle loss part? Yes, and it's a real problem. The loose skin claim? Mostly no, and this is where the video gets away from her.
GLP-1 receptor agonists cause significant fat-free mass loss alongside fat loss. A 2023 trial published in Nature Medicine (Wilding et al.) found that roughly 40% of weight lost on semaglutide came from lean body mass, not fat. Tirzepatide data from the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed similar lean mass reductions. This is not a minor side effect. It is a documented, consistent finding.
On the pilates question specifically: resistance training does rebuild skeletal muscle, even in people who have lost significant lean mass. A 2021 meta-analysis in Sports Medicine (Morton et al.) confirmed that progressive resistance training stimulates muscle protein synthesis regardless of prior deconditioning. Pilates, particularly reformer-based pilates, does provide enough mechanical load to stimulate muscle hypertrophy in previously sedentary individuals.
Loose skin, however, is a different tissue. It is primarily collagen and elastin in the dermis, not muscle. Exercise does not directly tighten skin that has lost structural support due to prolonged stretching from fat mass or age-related collagen loss.
What did they get wrong (or right)?
She got the muscle loss part right. Two years of GLP-1 use with minimal resistance training almost certainly produced meaningful sarcopenic changes. The science is clear on that. Credit where it's due: she's not pretending this didn't happen, and she's actually doing something about it.
What she got wrong, or at least oversimplified, is the loose skin narrative. She says pilates is "gonna be great to get that loose skin on the inner thighs gone" and calls specific movements "good for the loose skin." This is not accurate. Building muscle underneath loose skin can improve the appearance of the area by adding volume, but it does not eliminate or substantially reduce loose skin itself. Skin tightening depends on skin elasticity, age, genetics, the degree of prior stretching, and time. Exercise is not a primary driver of that process.
A 2019 review in Plastic and Reconstructive Surgery (Shermak) noted that individuals who lose 50+ pounds frequently retain excess skin that does not resolve with exercise, and many require surgical intervention. She acknowledged this herself, joking that her arms are "maybe always surgery crazy." That self-awareness is actually the most scientifically accurate thing she said about skin.
What should you actually know?
If you are on or coming off a GLP-1 medication, the muscle loss issue deserves serious attention. The standard clinical recommendation, supported by the American College of Sports Medicine and multiple obesity medicine guidelines, is to pair GLP-1 therapy with progressive resistance training from the start, not after you've finished the medication.
Protein intake matters too. Research from Cava et al. (2017, Advances in Nutrition) and subsequent work in GLP-1 populations suggests that adequate dietary protein (typically 1.2 to 1.6 grams per kilogram of body weight) combined with resistance training significantly attenuates lean mass loss during caloric restriction.
Pilates is a reasonable starting point for someone returning to exercise after a long break. It is low-injury-risk and builds foundational strength. But if rebuilding significant muscle mass is the goal, progressive overload with increasing resistance, not bodyweight pilates alone, is what the literature supports. Think of pilates as the entry ramp, not the highway.
On loose skin: manage your expectations. Exercise helps the appearance. It rarely eliminates the skin itself. Anyone telling you otherwise is selling something.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Semaglutide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Does Ozempic really destroy muscle, and can pilates fix it?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this semaglutide video claims cluster
Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.
Claim verdict
The useful answer behind this video
Claim being checked
After two years on tirzepatide (Mounjaro) with minimal resistance training, this creator presents a clinically common post-GLP-1 phenotype: significant weight loss accompanied by lean body mass reduction and residual loose skin, particularly in the arms, inner thighs, and abdomen.
FormBlends verdict
After two years on tirzepatide (Mounjaro) with minimal resistance training, this creator presents a clinically common post-GLP-1 phenotype: significant weight loss accompanied by lean body mass reduction and residual loose skin, particularly in the arms, inner thighs, and abdomen. She is now initiating reformer pilates as a muscle-rebuilding intervention, which is consistent with evidence-based recommendations for resistance training post-GLP-1 therapy, though pilates alone may be insufficient stimulus for full lean mass restoration without concurrent progressive overload and adequate protein intake. Loose skin in the areas she describes is unlikely to resolve with exercise alone and may require dermatological or surgical evaluation depending on severity.
Patient-safe next step
Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- After two years on tirzepatide (Mounjaro) with minimal resistance training, this creator presents a clinically common post-GLP-1 phenotype: significant weight loss accompanied by lean body mass reduction and residual loose skin, particularly in the arms, inner thighs, and abdomen. She is now initiating reformer pilates as a muscle-rebuilding intervention, which is consistent with evidence-based recommendations for resistance training post-GLP-1 therapy, though pilates alone may be insufficient stimulus for full lean mass restoration without concurrent progressive overload and adequate protein intake. Loose skin in the areas she describes is unlikely to resolve with exercise alone and may require dermatological or surgical evaluation depending on severity.
- In the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM), tirzepatide produced an average 20.9% reduction in body weight, with lean mass comprising a significant portion of that loss, particularly in participants who did not do structured resistance training.
- Roughly 40% of weight lost on semaglutide comes from lean body mass, not fat, according to 2023 data published in Nature Medicine, making muscle preservation a clinical priority during GLP-1 therapy, not an afterthought.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.
Review Compounded SemaglutideWhat You'll Learn
- In the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM), tirzepatide produced an average 20.9% reduction in body weight, with lean mass comprising a significant portion of that loss, particularly in participants who did not do structured resistance training.
- Roughly 40% of weight lost on semaglutide comes from lean body mass, not fat, according to 2023 data published in Nature Medicine, making muscle preservation a clinical priority during GLP-1 therapy, not an afterthought.
- Progressive resistance training, not pilates alone, is the evidence-supported intervention for rebuilding lean mass after GLP-1-related muscle loss. Pilates is a reasonable starting point but typically lacks sufficient progressive overload for significant hypertrophy.
- Protein intake of 1.2 to 1.6 grams per kilogram of body weight daily, combined with resistance training, significantly reduces lean mass loss during GLP-1-driven caloric restriction, per Cava et al. (2017, Advances in Nutrition).
- Exercise does not eliminate loose skin. It can improve appearance by adding muscle volume beneath the skin, but excess skin after major weight loss is a dermal tissue issue that frequently requires medical or surgical evaluation.
- Starting resistance training after stopping GLP-1 medications is better than never starting, but muscle rebuilding timelines are long. Expect meaningful changes over months, not the duration of a TikTok series.
- Anyone on a GLP-1 medication who has not started resistance training yet should speak with a provider or certified exercise physiologist about programming, not wait until after they finish the medication.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Chanelica.R · TikTok creator
31.7K views on this video
Rebuilding my muscle after losing it on Ozempic #fypp #workout #pilates @Club Pilates
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Chanelica.R, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.